144 related articles for article (PubMed ID: 33171279)
21. Effect of (m)RVD-hemopressin against Aβ1-42-induced apoptosis and inhibition of neurite outgrowth in SH-SY5Y cells.
Zhang R; Luan J; Hu F; Lv J; Zhang J; Li K; Guo H; Cheng J; Chen P; Zhang Y; Cai Q; Gou X
Neuropeptides; 2020 Jun; 81():102044. PubMed ID: 32241604
[TBL] [Abstract][Full Text] [Related]
22. MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice.
Dillon GM; Lubbers LS; Ferguson MT; Lao JZ; Huang RR; Xiao JC; Fong TM; Hale JJ; Rupprecht K; Miao S; Rowe BA; Kornecook TJ; Dodart JC
Behav Pharmacol; 2011 Apr; 22(2):91-100. PubMed ID: 21301326
[TBL] [Abstract][Full Text] [Related]
23. Investigation of receptor binding and functional characteristics of hemopressin(1-7).
Dvorácskó S; Tömböly C; Berkecz R; Keresztes A
Neuropeptides; 2016 Aug; 58():15-22. PubMed ID: 26895730
[TBL] [Abstract][Full Text] [Related]
24. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.
Dodd GT; Mancini G; Lutz B; Luckman SM
J Neurosci; 2010 May; 30(21):7369-76. PubMed ID: 20505104
[TBL] [Abstract][Full Text] [Related]
25. An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB
Xie JF; Wang LX; Ren WT; Wang C; Gao JX; Chen HL; Zhao XQ; Ren YL; Xie YP; Shao YF; Hou YP
Front Pharmacol; 2023; 14():1213215. PubMed ID: 37456761
[TBL] [Abstract][Full Text] [Related]
26. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
[TBL] [Abstract][Full Text] [Related]
27. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice.
Wang P; Zheng T; Zhang M; Xu B; Zhang R; Zhang T; Zhao W; Shi X; Zhang Q; Fang Q
Brain Res Bull; 2018 May; 139():48-55. PubMed ID: 29425797
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks.
Han RW; Zhang RS; Xu HJ; Chang M; Peng YL; Wang R
Neuropharmacology; 2013 Jul; 70():261-7. PubMed ID: 23454528
[TBL] [Abstract][Full Text] [Related]
30. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
[TBL] [Abstract][Full Text] [Related]
31. The NK3 receptor agonist senktide ameliorates scopolamine-induced deficits in memory for object, place and temporal order.
Schäble S; Huston JP; Barros M; Tomaz C; de Souza Silva MA
Neurobiol Learn Mem; 2012 Feb; 97(2):235-40. PubMed ID: 22209911
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
[TBL] [Abstract][Full Text] [Related]
33. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits.
Subbanna S; Shivakumar M; Psychoyos D; Xie S; Basavarajappa BS
J Neurosci; 2013 Apr; 33(15):6350-66. PubMed ID: 23575834
[TBL] [Abstract][Full Text] [Related]
34. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
35. Anxiogenic-like effects induced by hemopressin in rats.
Fogaça MV; Sonego AB; Rioli V; Gozzo FC; Dale CS; Ferro ES; Guimarães FS
Pharmacol Biochem Behav; 2015 Feb; 129():7-13. PubMed ID: 25462856
[TBL] [Abstract][Full Text] [Related]
36. Novel endogenous peptide agonists of cannabinoid receptors.
Gomes I; Grushko JS; Golebiewska U; Hoogendoorn S; Gupta A; Heimann AS; Ferro ES; Scarlata S; Fricker LD; Devi LA
FASEB J; 2009 Sep; 23(9):3020-9. PubMed ID: 19380512
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the cannabinoid receptors by hemopressin peptides.
Bomar MG; Galande AK
Life Sci; 2013 Mar; 92(8-9):520-4. PubMed ID: 22884803
[TBL] [Abstract][Full Text] [Related]
38. Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
Heimann AS; Gomes I; Dale CS; Pagano RL; Gupta A; de Souza LL; Luchessi AD; Castro LM; Giorgi R; Rioli V; Ferro ES; Devi LA
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20588-93. PubMed ID: 18077343
[TBL] [Abstract][Full Text] [Related]
39. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
[TBL] [Abstract][Full Text] [Related]
40. Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors.
El Swefy S; Hasan RA; Ibrahim A; Mahmoud MF
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):103-16. PubMed ID: 26475620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
